Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Understanding Patient Perspective, Challenges, Behavioral Patterns, and Preferences Towards Participation in Multiple Myeloma Clinical Trials: A Prospective Study

Sikander Ailawadhi, Jay R. Hydren, Leyla Bojanini, Nathan W. Sweeney, Felicia Seng, Mizba Baksh, Ahsan Rasheed, Mays Abdulazeez, Meghna Ailawadhi, Keren George, Ricardo D Parrondo, Vivek Roy, Victoria R. Alegria, Pooja Advani, Rami Manochakian, Jason S. Starr, Taimur Sher, Jennifer M. Ahlstrom, Asher Chanan-Khan

Blood (2022) 140 (Supplement 1): 7941–7942.

https://doi.org/10.1182/blood-2022-167005

Published: 2022

Journal Articles

Racial Disparities and Their Impact on Knowledge, Behavioral Patterns, and Preferences Towards Participation in Clinical Trials Among Cancer Patients

Meghna Ailawadhi, MD, Mays F Abdulazeez, MBBS, Leyla Bojanini Molina, MD, Victoria R. Alegria, Taimur Sher, MD, Vivek Roy, MD, Rami Manochakian, MD, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-140390

Published: 2020

Journal Articles

A Population-Based Analysis of Predictors of Survival and Trends in Outcomes of Elderly Patients with Multiple Myeloma (MM)

Vivek Kumar, MD, M.B.,B.S., Meghna Ailawadhi, MD, Mays F Abdulazeez, MBBS, Suman Biswas, MD, Sri Lekha Bodepudi, Leyla Bojanini, MD, Vivek Roy, MD, Taimur Sher, MD, Victoria R. Alegria, Rami Manochakian, MD, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi, MD

Blood (2019) 134 (Supplement_1): 4779.

https://doi.org/10.1182/blood-2019-125156

Published: 2019

Journal Articles

Disparities and Their Impact on the Adoption of Health Information Technology (HIT) in Minority Cancer Patients and Caregivers

Sikander Ailawadhi, MD, Meghna Ailawadhi, MD, Srilekha Bodepudi, Mays F Abdulazeez, BMSC, Zan Tahir Shareef, Ashna Grover, Maria J Fernandez, Winston Tan, MD, Victoria R. Alegria, Taimur Sher, MD, Vivek Roy, MD, Rami Manochakian, MD, Aneel Paulus, MD, Asher A. Chanan-Khan, MD

Blood (2019) 134 (Supplement_1): 411.

https://doi.org/10.1182/blood-2019-125722

Published: 2019

Journal Articles

Sociodemographic and Clinical Characteristics Associated with Patient's Decision to Refuse Multiple Myeloma (MM) Treatment, and Its Impact on Outcomes

Vivek Kumar, MD, M.B.,B.S., Mays F Abdulazeez, MBBS, Srilekha Bodepudi, Suman Biswas, Vivek Roy, MD, Taimur Sher, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi, MD

Blood (2019) 134 (Supplement_1): 3494.

https://doi.org/10.1182/blood-2019-125888

Published: 2019

Journal Articles

Trends in Early Mortality from Multiple Myeloma (MM): A Population-Based Analysis

Vivek Kumar, MD, M.B.,B.S., Mays F Abdulazeez, BMSC, Suman Biswas, MD, Sri Lekha Bodepudi, Vivek Roy, MD, Taimur Sher, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Salman Ahmed, MD, Prachi Jani, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi, MD

Blood (2019) 134 (Supplement_1): 71.

https://doi.org/10.1182/blood-2019-124799

Published: 2019

Journal Articles

Timeliness of Initial Therapy in Multiple Myeloma (MM): Trends and Factors Influencing Patient Care

Vivek Kumar, MD, M.B.,B.S., Taimur Sher, MD, Leyla Bojanini, MD, Prakash Vishnu, MD, Vivek Roy, MD, Rami Manochakian, MD, Sri Lekha Bodepudi, Zan Tahir Shareef, Salman Ahmed, MD, Prachi Jani, MD, Victoria R. Alegria, Meghna Ailawadhi, MD, Aneel Paulus, MD, Sonikpreet Aulakh, MD, Madiha Iqbal, MBBS, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2018) 132 (Supplement 1): 4764.

https://doi.org/10.1182/blood-2018-99-120127

Published: 2018

Journal Articles

Trends in the Utilization of Radiation Therapy (XRT) Among Patients with Non-Hodgkin's Lymphoma (NHL) in the United States (US)

Vivek Kumar, MD, M.B.,B.S., Taimur Sher, MD, Prakash Vishnu, MD, Vivek Roy, MD, Anne M Hazen, A.R.N.P.,M.S.N, Victoria R. Alegria, Meghna Ailawadhi, MD, Salman Ahmed, MD, Prachi Jani, MD, Zan Tahir Shareef, Sri Lekha Bodepudi, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2018) 132 (Supplement 1): 4765.

https://doi.org/10.1182/blood-2018-99-119981

Published: 2018

Journal Articles

Disparity in Clinical Trial Opportunities for Patients with B-Cell Malignancies in the United States

Sikander Ailawadhi, Sri Lekha Bodepudi, Zan Tahir Shareef, Fabiola Coromoto Cardozo, Salman Ahmed, MD, Prachi Jani, MD, Shishir David, Vivek Roy, MD, Aneel Paulus, MD, Victoria R. Alegria, Vivek Kumar, MD, M.B.,B.S., Meghna Ailawadhi, MD, Prakash Vishnu, MD, Sonikpreet Aulakh, MD, Rami Manochakian, MD, Asher A. Chanan-Khan, MD, Taimur Sher, MD

Blood (2018) 132 (Supplement 1): 4861.

https://doi.org/10.1182/blood-2018-99-117155

Published: 2018

Journal Articles

Trends in the Risk of Second Primary Malignancies (SPMs) Among Survivors of Chronic Lymphocytic Leukemia(CLL)

Vivek Kumar, MD, M.B.,B.S., Sikander Ailawadhi, Leyla Bojanini, MD, Aditya Mehta, Anshika Singh, Taimur Sher, MD, Vivek Roy, MD, Prakash Vishnu, MD, Julian A Marin-Acevedo, Victoria R. Alegria, Aneel Paulus, MD, Sonikpreet Aulakh, MD, Madiha Iqbal, MBBS, Rami Manochakian, MD, Winston Tan, MD, Asher A. Chanan-Khan, MD, Meghna Ailawadhi, MD

Blood (2018) 132 (Supplement 1): 4869.

https://doi.org/10.1182/blood-2018-99-116361

Published: 2018

Journal Articles

Sociodemographic Profile and Outcomes of Patients with Non-Diffuse Large B-Cell Lymphoma (non-DLBCL) Treated at Minority-Predominant Facilities in the United States

Vivek Kumar, MD, M.B.,B.S., Taimur Sher, MD, Vivek Roy, MD, Prakash Vishnu, MD, Anne M Hazen, A.R.N.P.,M.S.N, Victoria R. Alegria, Meghna Ailawadhi, MD, Sri Lekha Bodepudi, Zan Tahir Shareef, Fabiola Coromoto Cardozo, Salman Ahmed, MD, Prachi Jani, MD, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2018) 132 (Supplement 1): 4868.

https://doi.org/10.1182/blood-2018-99-119976

Published: 2018

Journal Articles

Factors Determining Utilization of Stem Cell Transplant (SCT) for Initial Therapy of Multiple Myeloma (MM) By Patient Race: Exploring Intra-Racial Healthcare Disparities

Sikander Ailawadhi, Ryan D. Frank, Nicolette T. Chimato, Zahara Meghji, Raj Patel, MD, Prachi Jani, MD, Tanya S. Kakar, Mark A. Fiala, BS, Sonikpreet Aulakh, MD, David O. Hodge, MS, Taimur Sher, MD, Vivek Roy, MD, Prakash Vishnu, MD FACP, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD

Blood (2017) 130 (Supplement 1): 860.

https://doi.org/10.1182/blood.V130.Suppl_1.860.860

Published: 2017

Journal Articles

Utilization of Palliative Care Among Patients with Hematologic Malignancies: An Extensive National Analysis to Define Trends and Patterns

Sikander Ailawadhi, Ryan D. Frank, Nicolette T. Chimato, Prachi Jani, MD, Aaron C. Spaulding, Mark A. Fiala, BS, Judith Kaur, MD, David O. Hodge, MS, Taimur Sher, MD, Vivek Roy, MD, Prakash Vishnu, MD FACP, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Dorin T. Colibaseanu, MD

Blood (2017) 130 (Supplement 1): 2107.

https://doi.org/10.1182/blood.V130.Suppl_1.2107.2107

Published: 2017

Journal Articles

Survival Trends in Young Patients with Multiple Myeloma: Focus on Racial-Ethnic Minorities

Sikander Ailawadhi, Abdel-Ghani Azzouqa, MD, David O. Hodge, MS, Jordan Cochuyt, Zahara Meghji, Raj Patel, MD, Prachi Jani, MD, Tanya S. Kakar, Ankita Aggarwal, Taimur Sher, MD, Vivek Roy, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD

Blood (2017) 130 (Supplement 1): 2149.

https://doi.org/10.1182/blood.V130.Suppl_1.2149.2149

Published: 2017

Journal Articles

Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma

Sikander Ailawadhi, Abdel-Ghani Azzouqa, Zahara Meghji, Tania Jain, MD, Nancy Diehl, Stephanie P. Gebhardt, Vishal Shah, David O. Hodge, MS, Raj Patel, MD, Prachi Jani, MD, Taimur Sher, MD, Vivek Roy, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Rafael Fonseca, MD

Blood (2017) 130 (Supplement 1): 5440.

https://doi.org/10.1182/blood.V130.Suppl_1.5440.5440

Published: 2017

Journal Articles

Utilization of Radiation Therapy in Multiple Myeloma: Trends and Changes in Practice

Sikander Ailawadhi, Ryan D. Frank, Zahara Meghji, Prachi Jani, MD, Raj Patel, MD, Mark A. Fiala, BS, Tanya S. Kakar, Sonikpreet Aulakh, MD, Ankita Aggarwal, David O. Hodge, MS, Taimur Sher, MD, Vivek Roy, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Prakash Vishnu, MD FACP, Aneel Paulus, MD, Asher A. Chanan-Khan, MD

Blood (2017) 130 (Supplement 1): 3395.

https://doi.org/10.1182/blood.V130.Suppl_1.3395.3395

Published: 2017

NARROW

Understanding Patient Perspective, Challenges, Behavioral Patterns, and Preferences Towards Participation in Multiple Myeloma Clinical Trials: A Prospective Study

Racial Disparities and Their Impact on Knowledge, Behavioral Patterns, and Preferences Towards Participation in Clinical Trials Among Cancer Patients

A Population-Based Analysis of Predictors of Survival and Trends in Outcomes of Elderly Patients with Multiple Myeloma (MM)

Disparities and Their Impact on the Adoption of Health Information Technology (HIT) in Minority Cancer Patients and Caregivers

Sociodemographic and Clinical Characteristics Associated with Patient's Decision to Refuse Multiple Myeloma (MM) Treatment, and Its Impact on Outcomes

Trends in Early Mortality from Multiple Myeloma (MM): A Population-Based Analysis

Timeliness of Initial Therapy in Multiple Myeloma (MM): Trends and Factors Influencing Patient Care

Trends in the Utilization of Radiation Therapy (XRT) Among Patients with Non-Hodgkin's Lymphoma (NHL) in the United States (US)

Disparity in Clinical Trial Opportunities for Patients with B-Cell Malignancies in the United States

Trends in the Risk of Second Primary Malignancies (SPMs) Among Survivors of Chronic Lymphocytic Leukemia(CLL)

Sociodemographic Profile and Outcomes of Patients with Non-Diffuse Large B-Cell Lymphoma (non-DLBCL) Treated at Minority-Predominant Facilities in the United States

Factors Determining Utilization of Stem Cell Transplant (SCT) for Initial Therapy of Multiple Myeloma (MM) By Patient Race: Exploring Intra-Racial Healthcare Disparities

Utilization of Palliative Care Among Patients with Hematologic Malignancies: An Extensive National Analysis to Define Trends and Patterns

Survival Trends in Young Patients with Multiple Myeloma: Focus on Racial-Ethnic Minorities

Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma

Utilization of Radiation Therapy in Multiple Myeloma: Trends and Changes in Practice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only